Connect with us
The Drug Controller General of India (DCGI) on Wednesday allowed the conduct of the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in...
Sources said on Monday that the government is considering allowing a booster dose of the Kovid-19 vaccine for all people above the age of 18 years...
India’s apex body on vaccination, NTAGI, has recommended giving a second dose of the Covid-19 vaccine Covishield between eight and 16 weeks after the first dose,...
With the resurgence of COVID-19 cases in Southeast Asia and some European countries, the Center has advised states and union territories to continue to focus on...
India’s drug regulator has granted Restricted Emergency Use Authorization to Serum Institute of India’s COVID-19 vaccine Kovovax for 12-17 years of age group, subject to certain...
{{posts.brief}} {{postss.image_caption}} {{postss.key_highlights.key_highlights1}} {{postss.key_highlights.key_highlights2}} {{postss.key_highlights.key_highlights3}} ,